Clinical Trial: Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia
Sponsor and Collaborators
Millennium Pharmaceuticals, Inc.
Contact: Richa Rajwanshi
Bruno Carneiro de Medeiros Stanford University
Next post in Leukemia Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.